The Europe synthetic biology market is expected to grow from US$ 3,111.58 million in 2021 to US$ 11,362.83 million by 2028; it is estimated to grow at a CAGR of 20.3% from 2021 to 2028.

Many start-ups are emerging in developing countries, as governments are providing funds for the domestic development of synthetic biology. Siolta Therapeutics produces therapeutic microbial consortia to prevent and treat inflammatory illnesses. It evaluates clinical data and develops mixed-species therapies for oral supplementation. Unlike existing medications for allergies, the microbiome-based approach operates before the onset of the immune dysfunction cascade. STMC-103H, a flagship therapeutic candidate of Siolta Therapeutics, is being studied for the treatment of allergic asthma as well as other chronic inflammatory illnesses, including atopic dermatitis and allergic rhinitis. Similarly, Kinnva Ltd., established in 2017, is a synthetic biology start-up catering to biotech, cleantech, and Agri-tech segments. Using a unique fermentation technology and sophisticated processing methods, Kinnva produces high value biochemicals for applications in the food, feed, nutraceuticals, and cosmetics industries. Thus, start-ups are contributing significantly to the synthetic biology market expansion across the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe synthetic biology market . The Europe synthetic biology market is expected to grow at a significant CAGR during the forecast period.

Europe Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

Europe Synthetic Biology Market Segmentation

The Europe synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to continue to grow at the fastest rate during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to grow at the fastest CAGR during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to grow at the highest CAGR during the forecast period. The Europe synthetic biology market is segmented into the UK, Germany, France, Italy, Spain, and Rest of Europe.

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the Europe synthetic biology market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Synthetic Biology Market – By Product
1.3.2 Europe Synthetic Biology Market – By Technology
1.3.3 Europe Synthetic Biology Market – By Application
1.3.4 Europe Synthetic Biology Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Synthetic Biology Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Synthetic Biology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Accentuating Investments in Synthetic Biology
5.1.2 Surging Number of Start-Ups
5.2 Key Market Restraints
5.2.1 Renewed Regulations for Biotechnology
5.3 Key Market Opportunities
5.3.1 Collaboration Between Companies
5.4 Future Trends
5.4.1 Advanced Synthetic Biology
5.5 Impact Analysis
6. Synthetic Biology Market– Europe Analysis
6.1 Europe Synthetic Biology Market Revenue Forecast and Analysis
7. Europe Synthetic Biology Market Analysis – By Product
7.1 Overview
7.2 Europe Synthetic Biology Market, By Product, 2021 & 2028 (%)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzyme: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Oligonucleotides
7.4.1 Overview
7.4.2 Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Chassis Organisms
7.5.1 Overview
7.5.2 Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Xeno-Nucleic Acids
7.6.1 Overview
7.6.2 Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
8. Europe Synthetic Biology Market Analysis – By Technology
8.1 Overview
8.2 Europe Synthetic Biology Market Share by Technology – 2021 & 2028 (%)
8.3 Gene Synthesis
8.3.1 Overview
8.3.2 Gene Synthesis: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genome Engineering
8.4.1 Overview
8.4.2 Genome Engineering: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.5 Measurement and Modeling
8.5.1 Overview
8.5.2 Measurement and Modeling: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.6 Cloning and Sequencing
8.6.1 Overview
8.6.2 Cloning and Sequencing: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.7 Nanotechnology
8.7.1 Overview
8.7.2 Nanotechnology: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Synthetic Biology Market Analysis – By Application
9.1 Overview
9.2 Europe Synthetic Biology Market Share by Application – 2021 & 2028 (%)
9.3 Medical Applications
9.3.1 Overview
9.3.2 Medical Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.3.2.1 Drug Discovery and Therapeutics
9.3.2.1.1 Overview
9.3.2.1.2 Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.3.2.2 Pharmaceuticals
9.3.2.2.1 Overview
9.3.2.2.2 Pharmaceuticals: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.4 Industrial Applications
9.4.1 Overview
9.4.2 Industrial Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.5 Food & Agriculture
9.5.1 Overview
9.5.2 Food & Agriculture: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.6 Environmental Applications
9.6.1 Overview
9.6.2 Environmental Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Synthetic Biology Market – Country Analysis
10.1 Europe: Synthetic Biology Market
10.1.1 Europe: Synthetic Biology Market, by Country, 2021 & 2028 (%)
10.1.1.1 UK: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 UK: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 UK: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.1.1.4 UK: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.1.1.5 UK: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.1.1.6 UK: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.1.2 Germany: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 Germany: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.1.2.4 Germany: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.1.2.5 Germany: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.1.2.6 Germany: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.1.3 France: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 France: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.1.3.4 France: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.1.3.5 France: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.1.3.6 France: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.1.4 Italy: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 Italy: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.1.4.4 Italy: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.1.4.5 Italy: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.1.4.6 Italy: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.1.5 Spain: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3 Spain: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.1.5.4 Spain: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.1.5.5 Spain: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.1.5.6 Spain: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.1.6 Rest of Europe: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of Europe: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.1.6.4 Rest of Europe: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.1.6.5 Rest of Europe: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.1.6.6 Rest of Europe: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Agilent Technologies, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MERCK KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 New England Biolabs
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Integrated DNA Technologies
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Twist Bioscience
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GenScript Biotech Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novozymes A/S
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Codexis
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amyris Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Synthetic Biology Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. UK: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 3. UK: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 4. UK: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 5. UK: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 6. Germany: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 7. Germany: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 8. Germany: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 9. Germany: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 10.   France: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 11.   France: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 12.   France: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 13.   France: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 14.   Italy: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 15.   Italy: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 16.   Italy: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 17.   Italy: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 18.   Spain: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 19.   Spain: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 20.   Spain: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 21.   Spain: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 22.   Rest of Europe: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 23.   Rest of Europe: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 24.   Rest of Europe: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 25.   Rest of Europe: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 26.   Organic Developments
Table 27.   Inorganic Developments
Table 28.   Glossary of Terms
 
 

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe synthetic biology market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe synthetic biology market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the synthetic biology market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Europe Synthetic Biology Market

● Agilent Technologies, Inc.
● Amyris
● Codexis
● Genscript Biotech corporation
● Integrated DNA Technologies
● Merck KGaA
● New England Biolabs
● Novozymes A/S
● Thermo Fisher Scientific
● Twist Bioscience